152 related articles for article (PubMed ID: 8585046)
1. Unusual bleeding manifestations in a case of primary amyloidosis with factor X deficiency but elevations of in vivo markers of thrombin formation and activity.
Marcatti M; Mauri S; Tresoldi M; Sabbadini MG; Vigano'D'Angelo S; Safa O; Rugarli C; D'Angelo A
Thromb Res; 1995 Nov; 80(4):333-7. PubMed ID: 8585046
[TBL] [Abstract][Full Text] [Related]
2. Bleeding symptoms and coagulation abnormalities in 337 patients with AL-amyloidosis.
Mumford AD; O'Donnell J; Gillmore JD; Manning RA; Hawkins PN; Laffan M
Br J Haematol; 2000 Aug; 110(2):454-60. PubMed ID: 10971408
[TBL] [Abstract][Full Text] [Related]
3. Prolongation of thrombin and reptilase times in patients with amyloidosis and acquired factor X deficiency.
Butler WM; Baldwin PE
South Med J; 1984 May; 77(5):648-51. PubMed ID: 6372111
[TBL] [Abstract][Full Text] [Related]
4. Role of individual factor X concentrate pharmacokinetic studies in perioperative management of AL amyloidosis-associated acquired factor X deficiency.
Lewis AR; Peffley N; Klompas AM; Ashrani AA
Transfusion; 2023 Sep; 63(9):1773-1777. PubMed ID: 37427705
[TBL] [Abstract][Full Text] [Related]
5. Acquired Factor X Deficiency in Patients With Primary Light Chain Amyloidosis.
Dejhansathit S; Suvannasankha A
J Investig Med High Impact Case Rep; 2019; 7():2324709619832332. PubMed ID: 30947547
[TBL] [Abstract][Full Text] [Related]
6. Occurrence and management of severe bleeding episodes in patients with hereditary factor X deficiency.
Tarantino MD
Haemophilia; 2021 Jul; 27(4):531-543. PubMed ID: 34021672
[TBL] [Abstract][Full Text] [Related]
7. Molecular basis of the clotting defect in a bleeding patient missing the Asp-185 codon in the factor X gene.
Lu Q; Yang L; Manithody C; Wang X; Rezaie AR
Thromb Res; 2014 Nov; 134(5):1103-9. PubMed ID: 25179519
[TBL] [Abstract][Full Text] [Related]
8. Fatal bleeding due to acquired factor IX and X deficiency: a rare complication of primary amyloidosis; case report and review of the literature.
Ericson S; Shah N; Liberman J; Aboulafia DM
Clin Lymphoma Myeloma Leuk; 2014 Jun; 14(3):e81-6. PubMed ID: 24290671
[No Abstract] [Full Text] [Related]
9. Spontaneous major bleeding in acquired factor X deficiency secondary to AL-amyloidosis.
Enjeti AK; Walsh M; Seldon M
Haemophilia; 2005 Sep; 11(5):535-8. PubMed ID: 16128899
[TBL] [Abstract][Full Text] [Related]
10. Life-threatening bleeding and acquired factor V deficiency associated with primary systemic amyloidosis.
Emori Y; Sakugawa M; Niiya K; Kiguchi T; Kojima K; Takenaka K; Shinagawa K; Ishimaru F; Ikeda K; Tanimoto M; Yamasaki R; Ohara N; Harada M
Blood Coagul Fibrinolysis; 2002 Sep; 13(6):555-9. PubMed ID: 12192308
[TBL] [Abstract][Full Text] [Related]
11. [AL amyloidosis-associated factor X deficiency].
Croles FN; Beerenhout CH; Mulder AB; Meijer K; Nijziel MR
Ned Tijdschr Geneeskd; 2014; 158(6):A6678. PubMed ID: 24495369
[TBL] [Abstract][Full Text] [Related]
12. The missense Thr211Pro mutation in the factor X activation peptide of a bleeding patient causes molecular defect in the clotting cascade.
Ding Q; Shen Y; Yang L; Wang X; Rezaie AR
Thromb Haemost; 2013 Jul; 110(1):53-61. PubMed ID: 23677006
[TBL] [Abstract][Full Text] [Related]
13. Acquired factor X and antithrombin III deficiency in a patient with primary amyloidosis and nephrotic syndrome.
Quitt M; Aghai E; David M; Kohan R; Ben Ari Y; Froom P
Scand J Haematol; 1985 Aug; 35(2):155-7. PubMed ID: 3876596
[TBL] [Abstract][Full Text] [Related]
14. [Decreased Quick percentage, acquired factor X deficiency, hemarthrosis and ecchymosis: amyloidosis].
Bohler A; Lämmle B
Ther Umsch; 1999 Sep; 56(9):523-5. PubMed ID: 10517125
[TBL] [Abstract][Full Text] [Related]
15. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
[TBL] [Abstract][Full Text] [Related]
16. Clotting alterations in primary systemic amyloidosis.
Gamba G; Montani N; Anesi E; Palladini G; Capezzera M; Soldavini E; Merlini G
Haematologica; 2000 Mar; 85(3):289-92. PubMed ID: 10702818
[TBL] [Abstract][Full Text] [Related]
17. [A patient with AL amyloidosis and severe factor X deficiency has been in complete haematological remission with normal factor X activity for 7 years following high-dose chemotherapy. A case study and literature review].
Adam Z; Matýková M; Krejcí M; Pour L; Kissová J; Slechtová M; Chlupová G; Stavarová Y; Simonides J; Penka M; Mayer J; Hájek R
Vnitr Lek; 2010 Jan; 56(1):67-78. PubMed ID: 20184115
[TBL] [Abstract][Full Text] [Related]
18. Acquired factor X deficiency in light chain amyloidosis: a report of 2 Korean cases.
Ma Y; Kwon EH; Lee JE; Kim K; Kim HJ; Kim SH
Korean J Lab Med; 2011 Jul; 31(3):154-6. PubMed ID: 21779187
[TBL] [Abstract][Full Text] [Related]
19. Acquired combined factor X and XII deficiency with isolated bleeding complications in a patient with AL amyloidosis.
Wiest R; Klouche M; Härle P; Bross K; Blaszyk H; Fischereder M; Reng CM
Ann Hematol; 2005 Mar; 84(3):196-9. PubMed ID: 15551096
[No Abstract] [Full Text] [Related]
20. Bleeding manifestations in 100 patients with amyloidosis.
Yood RA; Skinner M; Rubinow A; Talarico L; Cohen AS
JAMA; 1983 Mar; 249(10):1322-4. PubMed ID: 6600795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
